The balance between comprehensively analyzing the proteome and using valuable mass spectrometry time is a genuine challenge in the field of proteomics. Multidimensional fractionation strategies have significantly increased proteome coverage, but often at the cost of increased mass analysis time, despite advances in mass spectrometer acquisition rates. 3
Introduction
Comprehensive proteomics has seen an increase in the number of peptides identified and quantified by shotgun strategies due to improved mass spectrometer acquisition rates 1 and advances in peptide separation strategies. Deep proteome coverage has been achieved by various multidimensional fractionation strategies that involve off-and on-line peptide fractionation methods, which reduce sample complexity prior to tandem mass spectrometry (MS/MS) analysis (reviewed in [2] [3] [4] [5] [6] ).
The performance of two-dimensional liquid chromatography (2D-LC) depends on the separation efficiency, or peak capacity, in both chromatographic dimensions and orthogonality of the two separation elements 7 . Fractionation of peptides and proteins increases the peak capacity of LC separation 8 . Off-line peptide fractionation based on a high pH reversed phase (RP) approach followed by on-line low pH RP provides high resolving power based on hydrophobic interactions, especially when a large number of fractions are collected in the first dimension 7, 9 . However, this increases the number of samples that need to be separated in the second dimension and, consequently, mass spectrometry analysis time. Indeed, high peptide coverage of human cell lines has been observed, but typically at the expense of longer MS acquisition time 10 . For instance, Nagaraj et al identified 10255 human proteins from HeLa cell lysates over 12 days (288 h) using tandem prefractionation by gel filtration at the protein level, digestion by three specific proteases, and strong anion exchange separation of peptides into 72 fractions 11 . Significant reduction in analysis time has been achieved by concatenating high pH RPLC fractions with minimal reduction (15-20%) in protein identification compared to non-concatenated samples 12 .
Moreover, concatenating multiple early, middle, and late fractions improved the orthogonality of RPLC-RPLC and increased protein sequence coverage when compared to strong cation exchange (SCX)-RPLC schemes 13 . Using this concatenated high pH RP -low pH RP 2D LC-MS/MS approach, Spicer et al achieved deep proteome coverage of a complex sample in relatively little MS analysis time, identifying 8757 proteins from tryptic digests of whole Jurkat cell lysates in 31.5 h on a Triple TOF 5600 instrument (21 fractions) 4 .
Recently, this concatenated 2D RP-RP LC-MS/MS approach has been applied to quantitative proteomics investigations. The advent of tandem mass spectrometry tags (TMTs) made quantitative proteomics of complex protein samples a reality 14 . These isobaric labeling reagents ensure that identical peptides labeled with different TMTs exactly comigrate in chromatographic separations, such that peptides from different samples can be accurately quantified 14 . The desire to profile thousands of proteins from different samples in a quantitative manner, and the need to balance efficiency, statistical power, and throughput led to multiplexing TMT reagents 15 . Indeed, with TMT 10-plex reagents, up to ten biological samples can be analyzed for proteome changes in a single MS experiment with wide dynamic range and excellent accuracy, on high-resolution instruments with advanced ion collection methods 1, [16] [17] [18] . Recently, two studies employed comparable TMT10-plex strategies to determine the expression level of proteins in four human cell lines 19 and ovarian tumour sections 20 . Both studies used high pH RP to fractionate the pooled TMT-labeled peptide sample into 96 fractions, which were concatenated into 10 and 12 samples, respectively. These samples were subsequently subjected to low pH RP on an EASY-nLC 1000 LC pump coupled to an Orbitrap Fusion mass spectrometer with MultiNotch MS3 analysis 17, 19, 20 . In total, 8590 proteins were quantified across 10 human cell lines in 36 h of LC-MS time 19 
Experimental Procedures
Sample preparation and TMT labeling Samples of nonsmall cell lung carcinoma (NSCLC) patient-derived xenografts (PDX) were obtained as previously described 22, 23 . To determine if the new Evosep One LC system could achieve similar numbers of protein identifications for multiplexed samples while using less mass spectrometry time, we established a novel workflow for the same TMT labelled PDX samples involving Evotips. High pH reversed phase HPLC fractionated 0.5 mg of starting material into 60 fractions, which were then lyophilized, resuspended in 100 l of 0.1% formic acid and loaded onto an Evotip. Given identified in at least two of the three replicates (Figure 2A ). With three unique peptides, 93.7%
of proteins were identified in all three replicates, and 99.5% of proteins identified in at least A key aspect to deep proteome analysis is the offline peptide separation strategy employed.
Ideally, this strategy separates peptides in a manner that minimizes overlap between adjacent fractions. To assess the effectiveness of our high pH reversed phase separation in the first dimension, we examined peptides that were common between fractions. We found an average 11.8% (1.1%) peptide overlap in adjacent side by side fractions across all fractions and all replicates ( Figure 5A ). Peptide overlap in alternate (separated by two) and distant (separated by five) fractions reduced to 3.9% (0.9%) and 1.5%, ( 0.4%), respectively ( Figure 5B , C).
This indicates that our first-dimension separation strategy efficiently and effectively separates complex PDX samples. As well, the number of MS/MS spectra observed per fraction was relatively uniformly distributed across the 60 fractions ( Figure 2C ), consistent with good orthogonality of our high pH -low pH HPLC/Evotip separation protocol. We noticed that very early and very late fractions (1-5 and 55-60, Figure 2C ) showed a marked reduction of MS/MS spectra, suggesting that these fractions may be combined with middle fractions to further reduce mass analysis time. To test the impact of concatenation of fractions prior to Evotip processing, we combined the 60 HPLC fractions into 30 fractions and proceeded with the Evosep 60 samples per day workflow as described above. While this experimental design reduced the mass analysis time to 12 hours, it also resulted in significantly fewer protein identifications (Table 1) . Specifically, the concatenated Evosep strategy produced 22.4% and 34.1% less protein identifications than when the 60 fractions were run individually with 60 samples per day and 30 samples per day workflows, respectively (Table 1 and Figure 1 ). Thus, unless mass spectrometry time is extremely limited or cost prohibitive, it is recommended that HPLC fractions not be concatenated prior to the Evosep One workflow. However, 
Conclusions
Achieving maximal efficiency of MS time and deep quantifiable proteome coverage is a collective goal in the field of proteomics. As the demand for deep proteomic analyses of cell lines and tissues increases, it is imperative that workflows optimize proteome coverage in a cost and time efficient manner. While the Evosep One liquid chromatography system was constructed for high throughput applications with a particular focus on clinical analysis 21 , we
show that this technology can be used to support data dependant acquisition of unknown TMT 
